| Firm |
Analyst |
| Rodman & Renshaw
|
Simos Simeonidis |
| Roth Capital Partners
|
Joseph Pantginis, PhD |
Oncothyreon is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Oncothyreon's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oncothyreon or its management. Oncothyreon does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
return to top ^
|
